Use a “chase-the-vessel-size” strategy: For larger facial vessels, begin with a relatively long pulse duration and sufficiently high fluence to heat and coagulate the vessel without immediate rupture. After vasoconstriction reduces the vessel diameter, use a shorter pulse duration—often around 10–20 ms—to deliver higher peak power to the remaining vessel volume; fluence should be adjusted conservatively according to the tissue response and the specific device.
The principle is sequential thermal matching: start with longer, controlled heating for the larger vessel, then shorten the pulse as the vessel constricts. Do not automatically increase fluence with every pass; the goal is effective coagulation with the lowest energy that produces the intended endpoint without excessive epidermal or dermal injury.
Match Each Pass to the Changing Vessel
First pass: treat the original vessel diameter
For larger facial vessels, such as vessels in the alar groove, the initial pass commonly uses a longer pulse duration, for example 50–100 ms, with a fluence adequate to heat the full vessel wall.
The longer exposure distributes energy more gradually through the larger blood volume and vessel wall. This reduces the likelihood of abrupt vaporization, wall rupture, bleeding, and excessive purpura.
Subsequent pass: treat the constricted vessel
Thermal injury causes the vessel to constrict and its effective diameter to decrease. A second pass can therefore use a shorter pulse duration, commonly around 10–20 ms, to match the smaller residual target.
The shorter pulse produces greater peak power for the same general energy range, allowing the remaining oxyhemoglobin and vessel wall to be heated rapidly enough for further sealing and occlusion.
Fluence should follow the clinical endpoint
Fluence is not adjusted independently of pulse duration, vessel size, skin type, cooling, and the treatment endpoint. A longer first pulse may require substantial fluence to coagulate the larger vessel, while the shorter second pass should be introduced cautiously because the reduced vessel contains less target volume and can heat more rapidly.
The practical objective is progressive vessel closure, not maximal energy delivery. If the first pass already produces the desired vessel response, additional passes or higher fluence may increase risk without improving clearance.
Why Vessel Diameter Determines Pulse Duration
Larger vessels need slower heating
A larger vessel has a greater thermal mass and a longer thermal relaxation time. Longer pulses allow heat to spread through the vessel wall more uniformly before the energy dissipates or creates a focal rupture.
This is particularly important for larger facial vessels, where overly short, aggressive pulses can produce uneven heating, vessel rupture, or bleeding rather than controlled coagulation.
Smaller residual vessels need faster heating
After vasoconstriction, the remaining vessel volume is smaller and loses heat more rapidly. Shorter pulses help concentrate energy during the vessel’s shorter thermal relaxation period.
For fine telangiectasias, vascular devices may use pulse durations within a shorter range—approximately 0.45–40 ms, depending on vessel diameter, depth, wavelength, and device design. Exact settings must come from the system’s validated treatment parameters rather than from the time range alone.
Fluence and pulse duration are coupled
Increasing fluence while shortening pulse duration raises the rate at which energy is deposited. This can be useful for smaller residual vessels, but it also narrows the margin between effective photocoagulation and unwanted thermal injury.
Accordingly, a shorter second pass is not automatically a justification for a large fluence increase. The operator should evaluate the immediate response, cooling effectiveness, and cumulative energy from all passes.
How to Sequence the Treatment
Use the first pass to establish controlled coagulation
Begin with the longer-pulse pass over the larger vessel, using appropriate contact or integrated cooling when available. The desired result is controlled vessel blanching, darkening, or constriction according to the device and treatment protocol—not immediate tissue rupture.
Pulse overlap should be minimized. Repeatedly stacking pulses over the same site can create excessive cumulative heating even when each individual pulse appears acceptable.
Use the second pass selectively
Apply the shorter-pulse pass only after allowing the vessel to constrict and assessing the tissue response. The second pass should target the residual vessel rather than indiscriminately reheating the entire surrounding skin.
This approach is especially relevant when treating larger vessels in anatomically sensitive areas such as the alar groove, where depth, curvature, and local vascular anatomy can vary considerably.
Adjust across treatment sessions separately
Changes across treatment sessions are different from changes between passes in a single session. Early sessions may use more conservative energy, while later treatments may increase fluence or the number of passes if the lesion remains active and the prior response was safe.
Those adjustments should be guided by clearance, persistent vascularity, adverse effects, skin response, and the device manufacturer’s protocol—not by a fixed escalation schedule.
Understanding the Trade-offs
More energy is not always more effective
Higher fluence can improve coagulation when the target is undertreated, but it also increases the risk of purpura, blistering, prolonged erythema, pigmentary change, scarring, and other thermal complications.
Shortening the pulse while increasing fluence can be particularly aggressive because the peak power rises substantially. This combination should be reserved for an appropriately smaller residual target and used with careful endpoint monitoring.
Multi-pass treatment increases cumulative heat
Each pass contributes to total thermal exposure. Even if a second pass uses a shorter pulse, the skin may still retain heat from the first pass, making pulse overlap and closely repeated shots hazardous.
Adequate cooling, appropriate spacing, and avoidance of pulse stacking are important safeguards. Integrated sapphire contact cooling can help protect the epidermis, but it does not eliminate the risk of excessive dermal heating.
Purpura may be an expected but not harmless endpoint
Aggressive treatment of fine vessels may produce temporary purpura, but extensive purpura, blistering, gray or white tissue change, or disproportionate pain suggests excessive injury rather than simply better treatment.
The clinical endpoint must therefore be interpreted alongside the patient’s skin type, lesion depth, vessel caliber, wavelength, spot size, and device-specific pulse structure.
Common Parameter Errors to Avoid
Using one pulse duration for every pass
A fixed pulse duration ignores the fact that the target vessel changes after the first pass. Larger initial vessels and smaller constricted remnants have different thermal requirements.
Increasing fluence automatically on the second pass
The second pass may require a shorter pulse, but not necessarily a higher fluence. Because the target is smaller and heat is delivered more rapidly, maintaining or cautiously reducing fluence may be safer than escalating it.
Treating the reference values as universal settings
Values such as 50–100 ms for the initial pass and 10–20 ms for a later pass illustrate the strategy; they are not universally safe prescriptions. Device wavelength, fluence calibration, pulse format, spot size, cooling, vessel depth, skin pigmentation, and lesion characteristics can materially change the appropriate settings.
Applying the Strategy Safely
The following recommendations summarize the decision process rather than replace device-specific training or clinical protocols:
- If your primary focus is a larger facial vessel: Begin with a longer pulse and controlled fluence to coagulate the full vessel without rupture, then reassess before considering a shorter-pulse pass.
- If your primary focus is a constricted residual vessel: Shorten the pulse duration to match the smaller target, while adjusting fluence cautiously rather than assuming it must increase.
- If your primary focus is fine telangiectasia: Use a pulse duration matched to the vessel’s shorter thermal relaxation time and monitor closely for excessive purpura or collateral heating.
- If your primary focus is epidermal safety: Use effective contact cooling, minimize overlap, avoid pulse stacking, and account for cumulative energy across all passes.
- If your primary focus is treatment progression over several sessions: Escalate fluence or passes only when the clinical response justifies it and the previous treatment produced no concerning adverse effects.
Match the pulse to the vessel’s current size, and use fluence as a controlled tool—not as a substitute for thermal judgment.
Summary Table:
| Pass | Target Vessel Status | Pulse Duration | Fluence Adjustment | Rationale |
|---|---|---|---|---|
| First Pass | Original larger vessel | Longer (e.g., 50–100 ms) | Sufficient to coagulate vessel wall without rupture | Gradual heating of larger thermal mass |
| Subsequent Pass | Constricted residual vessel | Shorter (e.g., 10–20 ms) | Conservative; maintain or reduce, avoid automatic increase | Rapid heating of smaller target with higher peak power |
Achieve optimal results in facial vascular treatments with precision equipment from BELIS. Our advanced laser systems offer customizable pulse durations and fluences, enabling you to implement vessel-size strategies safely and effectively. Designed exclusively for clinics and premium salons, our portfolio includes diode, Alexandrite, CO2, and Nd:YAG lasers, ensuring you have the right tool for every procedure. Enhance your practice's outcomes and client satisfaction. Contact us today to learn how BELIS can support your clinical excellence.
Related Products
- 12D HIFU Machine Device for Facial HIFU Treatment
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
- 22D HIFU Machine Device Facial Machine
- 4D Vaginal HIFU and Face HIFU System
- 9D 7D HIFU Vaginal RF Lifting Treatment
People Also Ask
- What roles do ultrasound coupling gel and polyethylene film play in HIFU? Key to Safe and Precise Energy Delivery
- What is the mechanism of HIFU devices for facial lifting? Unlock Non-Surgical SMAS Tightening Secrets
- Is swelling a frequent side effect after a HIFU facial? Expert Insights on HIFU Recovery and Safety
- What is the mechanism of action of High-Intensity Focused Ultrasound (HIFU) devices in noninvasive body sculpting, and how is surrounding tissue protected?
- How do non-invasive lifting devices like high-intensity focused ultrasound (HIFU) complement soft tissue fillers in treating lower face aging and pre-jowl sulcus depression? Discover the synergistic approach.
